149 related articles for article (PubMed ID: 19452129)
21. Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administration.
Stevens J; Ploeger BA; van der Graaf PH; Danhof M; de Lange EC
Drug Metab Dispos; 2011 Dec; 39(12):2275-82. PubMed ID: 21903866
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
Kaur P; Kim K
Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
[TBL] [Abstract][Full Text] [Related]
23. Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats.
Feng J; Li F; Zhao Y; Feng Y; Abe Y
Int J Pharm; 2009 Jun; 375(1-2):55-60. PubMed ID: 19481691
[TBL] [Abstract][Full Text] [Related]
24. Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.
Sousa J; Alves G; Fortuna A; Falcão A
Pharm Res; 2017 Nov; 34(11):2260-2269. PubMed ID: 28748398
[TBL] [Abstract][Full Text] [Related]
25. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
Dhuria SV; Hanson LR; Frey WH
J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
[TBL] [Abstract][Full Text] [Related]
26. Effects of intranasal and peripheral oxytocin or gastrin-releasing peptide administration on social interaction and corticosterone levels in rats.
Kent P; Awadia A; Zhao L; Ensan D; Silva D; Cayer C; James JS; Anisman H; Merali Z
Psychoneuroendocrinology; 2016 Feb; 64():123-30. PubMed ID: 26658172
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.
Wang X; He H; Leng W; Tang X
Int J Pharm; 2006 Jul; 317(1):40-6. PubMed ID: 16631329
[TBL] [Abstract][Full Text] [Related]
28. Microdialysis evaluation of the brain distribution of stavudine following intranasal and intravenous administration to rats.
Yang Z; Huang Y; Gan G; Sawchuk RJ
J Pharm Sci; 2005 Jul; 94(7):1577-88. PubMed ID: 15920773
[TBL] [Abstract][Full Text] [Related]
29. Huperzine A in rat plasma and CSF following intranasal administration.
Yue P; Tao T; Zhao Y; Ren J; Chai X
Int J Pharm; 2007 Jun; 337(1-2):127-32. PubMed ID: 17241758
[TBL] [Abstract][Full Text] [Related]
30. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.
Ross TM; Martinez PM; Renner JC; Thorne RG; Hanson LR; Frey WH
J Neuroimmunol; 2004 Jun; 151(1-2):66-77. PubMed ID: 15145605
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
[TBL] [Abstract][Full Text] [Related]
32. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
[TBL] [Abstract][Full Text] [Related]
33. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.
Chow HS; Chen Z; Matsuura GT
J Pharm Sci; 1999 Aug; 88(8):754-8. PubMed ID: 10430537
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration.
Li N; Je YJ; Yang M; Jiang XH; Ma JH
Pharmazie; 2011 May; 66(5):374-7. PubMed ID: 21699072
[TBL] [Abstract][Full Text] [Related]
35. Intranasal administration delivers peptoids to the rat central nervous system.
Ross TM; Zuckermann RN; Reinhard C; Frey WH
Neurosci Lett; 2008 Jul; 439(1):30-3. PubMed ID: 18501511
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of tramadol in rat plasma and cerebrospinal fluid after intranasal administration.
Zhao Y; Tao T; Wu J; Pi J; He N; Chai X; Chen Q
J Pharm Pharmacol; 2008 Sep; 60(9):1149-54. PubMed ID: 18718117
[TBL] [Abstract][Full Text] [Related]
37. Nasal absorption of procyclidine in rats and dogs.
Jang EJ; Lee YJ; Chung SJ; Shim CK
Arch Pharm Res; 2001 Jun; 24(3):219-23. PubMed ID: 11440081
[TBL] [Abstract][Full Text] [Related]
38. Distribution of antihistamines into the CSF following intranasal delivery.
Chou KJ; Donovan MD
Biopharm Drug Dispos; 1997 May; 18(4):335-46. PubMed ID: 9158881
[TBL] [Abstract][Full Text] [Related]
39. The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.
Bagger MA; Bechgaard E
Eur J Pharm Sci; 2004 Feb; 21(2-3):235-42. PubMed ID: 14757495
[TBL] [Abstract][Full Text] [Related]
40. Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys.
Iwasaki S; Yamamoto S; Sano N; Tohyama K; Kosugi Y; Furuta A; Hamada T; Igari T; Fujioka Y; Hirabayashi H; Amano N
Pharm Res; 2019 Apr; 36(5):76. PubMed ID: 30937626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
